|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/08 | |
| A61K 38/17 | |||
| A61K 38/18 | |||
| A61K 38/19 | |||
| A61K 38/20 | |||
| A61K 38/21 | |||
| A61K 38/22 | |||
| G01N 33/50 |
| (11) | Patento numeris | 1853293 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 06718342.6 |
| Europos patento paraiškos padavimo data | 2006-01-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2007-11-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-12-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2006/001255 |
| Data | 2006-01-13 |
| (87) | Numeris | WO 2006/076588 |
| Data | 2006-07-20 |
| (30) | Numeris | Data | Šalis |
| 643307 P | 2005-01-13 | US |
| (72) |
GOLDSTEIN, Allan L., US
FINKELSTEIN, Jack, Jr., US
|
| (73) |
Regenerx Biopharmaceuticals, Inc.,
3 Bethesda Metro Center, Suite 630, Bethesda, Maryland 20814,
US
|
| (54) | THYMOSIN BETA 4 FOR TREATING MULTIPLE SCLEROSIS |
| THYMOSIN BETA 4 FOR TREATING MULTIPLE SCLEROSIS |